Outpatient cardiovascular diseases and diabetes medicines dispensing in the population with government health insurance in Syria between 2018 and 2019: a retrospective analysis

Table 2 Outpatient dispensing rates of CVDs medicines according to the therapeutic subgroup (ATC2)

	Therapeutic subgroup (ATC2)	DID^a		patients
	Therapeutic subgroup (ATC2)	n	%	n	%
Cardiovascular diseases medicine	Antithrombotic agents (B01)	90.54	15.31	9433	11.60
	Lipid-modifying agents (C10)	83.64	14.15	8765	10.78
	Renin-angiotensin system agents (C09)	64.48	10.91	8377	10.30
	Beta-blocking agents (C07)	30.48	5.16	6543	8.05
	Calcium-channel blockers (C08)	14.35	2.43	2031	2.48
	Cardiac therapy (C01)	9.26	1.57	1438	1.77
	Diuretics (C03)	8.12	1.37	1336	1.64
	Antihypertensives (C02)	1.00	0.17	334	0.41
	Peripheral vasodilators (C04)	0.18	0.03	230	0.28
	Vasoprotectives (C05)	0.04	0.01	2441	3.00
	Total	302.09	51.11	14,532^b	17.84^b

^aOutpatient medicines dispensing according to the therapeutic subgroup (ATC2) is expressed as the number of defined daily doses (DDDs) per 1000 people per day (DID)
^bSome patients dispensed different CVDs medicines. To avoid counting these patients more than once, we considered the identical number for each patient while calculating the total number and percentage of patients

ISSN: 1472-6963